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Abstract
Antibiotic-resistant bacteria, particularly Gram negative species, present significant health care challenges. The permeation
of antibiotics through the outer membrane is largely effected by the porin superfamily, changes in which contribute to
antibiotic resistance. A series of antibiotic resistant E. coli isolates were obtained from a patient during serial treatment with
various antibiotics. The sequence of OmpC changed at three positions during treatment giving rise to a total of four OmpC
variants (denoted OmpC20, OmpC26, OmpC28 and OmpC33, in which OmpC20 was derived from the first clinical isolate).
We demonstrate that expression of the OmpC K12 porin in the clinical isolates lowers the MIC, consistent with modified
porin function contributing to drug resistance. By a range of assays we have established that the three mutations that occur
between OmpC20 and OmpC33 modify transport of both small molecules and antibiotics across the outer membrane. This
results in the modulation of resistance to antibiotics, particularly cefotaxime. Small ion unitary conductance measurements
of the isolated porins do not show significant differences between isolates. Thus, resistance does not appear to arise from
major changes in pore size. Crystal structures of all four OmpC clinical mutants and molecular dynamics simulations also
show that the pore size is essentially unchanged. Molecular dynamics simulations suggest that perturbation of the
transverse electrostatic field at the constriction zone reduces cefotaxime passage through the pore, consistent with
laboratory and clinical data. This subtle modification of the transverse electric field is a very different source of resistance
than occlusion of the pore or wholesale destruction of the transverse field and points to a new mechanism by which porins
may modulate antibiotic passage through the outer membrane.
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Introduction
Multi-drug resistance is increasingly prevalent in clinically
important pathogens and threatens to hinder treatment of diseases
hitherto thought ‘‘cured’’. Bacterial resistance occurs by a
combination of a reduction in drug passage through the outer
membrane into the cell, modification of drug targets (protein or
the metabolic pathway), antibiotic degradation or increased
transport of antibiotic out of the cell. The outer membrane of
Gram negative bacteria presents a formidable barrier to polar
molecules. Porins, which are beta-barrel proteins that traverse the
bacterial outer membrane, facilitate the uptake of small polar
nutrients and are the main entry pathway for many antibiotics
[1,2]. Several clinical studies have linked antibiotic resistance to
altered expression of porins, or their restricted function due to
point mutation(s) (reviewed in [3]). The selection pressure for such
mutants must balance increased resistance against the loss of
capacity for nutrient access to the periplasm.
E. coli produces two major porins, OmpF and OmpC [2].
OmpC has a smaller effective channel than OmpF [4,5] and is
preferentially expressed in higher osmolarity environments, such
as the human gut [2]. Many antibiotic-resistant strains of E. coli
have reduced or no expression of OmpF [6,7] and this has been
taken as evidence that OmpF is the primary pathway for antibiotic
import [2]. More recently, it has been argued that the role of
OmpC in antibiotic resistance has been underestimated [3,8].
OmpC mutations have been detected in antibiotic resistant E. coli
strains isolated after antibiotic treatment [9,10] as well as in
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homolog (Omp36) have been reported [9].
The crystal structures of OmpF [11] and OmpC [12] show that
they are both built of 16 amphipathic b-strands arranged into a
barrel with a central pore. The strands are connected by long
extracellular loops (denoted L1, L2 etc) and short periplasmic
turns (Fig. 1a). Both proteins are found as trimers that are held
together by hydrophobic interactions between the barrel surfaces
and by the loop L2, each of the three L2 loops in the trimer
reaches into the adjacent monomer forming a conserved salt
bridge between L2’s glutamic acid and an arginine inside the
barrel [11–13] (Fig. 1a). L3 folds into the channel and narrows the
pore at about the half way point, forming a ‘‘constriction zone’’ or
‘‘eyelet’’ that governs the effective pore size [11,12]. At the eyelet,
there is a strong transverse electric field due to the presence of
conserved basic amino acid residues on the barrel wall facing
acidic residues on L3 (Fig. 1b). Due to conservation of the critical
residues this transverse field is found in all OmpC and OmpF
porins and it is proposed to govern ion selectivity and channel
permeability to polar molecules [14]. Zwitterionic antibiotics are
thought to bind at the entrance to the pore and interact with these
charged residues, which facilitates their translocation [15–17].
Blockage of the OmpF porin by various zwitterionic antibiotics
(e.g. penicillin) has been observed at high concentrations and
attributed to the binding events that precede their translocation
[18,19]. Constructed mutations of residues located at the
constriction zone of OmpF and other porins that alter the passage
of small molecules, including antibiotics, have been extensively
studied (reviewed in [3,8]). In many of these cases, the resistance
was caused by radical alteration to the hydrogen bond network
that constitutes the transverse charge field surrounding the pore
eyelet, not simply reduction of the pore size.
Detailed studies of clinically-resistant bacteria with modified
OmpC are relatively rare, but as the role of OmpC in antibiotic
transport becomes clearer the importance of such research grows
[8]. One study described a series of OmpC mutants isolated from
a patient with Caroli syndrome who had chronic E. coli infection of
liver cysts [10]. Seven E. coli isolates were collected, either from
blood samples or directly from liver abscesses over a two-year time
period [10]. Measurement of the minimum inhibitory concentra-
tions (MIC) for each of the prescribed antibiotics revealed that the
E. coli isolates had progressively greater antibiotic resistance
Figure 1. Structure of OmpC. (a) The trimer of OmpC20 viewed from the outside the cell, loop L2 (orange) reaches across from one monomer into
the pore of another making three salt contacts per trimer, L3 (magenta) forms the constriction zone and L4 (blue) contributes to trimer stability and
forms the entrance to the pore. (b) The constriction zone of OmpC20, the color scheme is as Fig. 1a. The side chains (carbon yellow, oxygen red,
nitrogen blue) of the charged residues at the constriction zone are labeled. The residues that are mutated in going from OmpC20 to OmpC33 are
underlined and shown in italic. Two of the three residues that are mutated in OmpC33 sit at the constriction zone, the third S271 sits behind L3.
Residue E66* from loop L2 from another subunit (shown with orange spheres at termini) reaches into the pore the salt bridge with R124. (c) The
structure, charge and molecular weight of the beta-lactam antibiotics. The number of the isolates in which clinically significant resistance occurs are
noted [10]. Isolates 1, 2 and 3 contained OmpC20, isolate 4 OmpC26, isolate 5 OmpC28 and isolates 6 and 7 OmpC33.
doi:10.1371/journal.pone.0025825.g001
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for particular antibiotics and there was no simple monotonic
increase in MIC against all antibiotics [10]. The authors noted the
E. coli isolates lacked OmpF expression and that there were three
sequential cumulative changes in the OmpC protein [10]. The
overall sequence of the OmpC protein from the first isolate
(OmpC20) is quite different from that found in the lab strain E. coli
K12 and it is thought that the infecting organisms evolved from
the uropathogenic E. coli strain O6, which expresses a related
OmpC protein (Fig. S1). The subsequent isolates retain this
sequence but have also acquired further changes: at D18E
(OmpC26), D18E S271F (OmpC28) and D18E, S271F, R124H
(OmpC33). Interpretation of the clinical data is complicated, as
other changes in the strains occurred in parallel, including
alteration of expression levels of other proteins, notably ß-
lactamases and in the last two strains OmpC expression itself
was decreased. We have combined structural studies with
biological and in silico simulations to investigate the mechanism
by which the porin mutations contribute to antibiotic resistance.
These data support a model in which perturbation of the
transverse electrostatic field by mutation, rather than steric
occlusion of the pore, is a major contributor to modified antibiotic
transport through the porin.
Results
A role for OmpC mutations in perturbing transport into E.
coli cells
To establish whether there was a role for the OmpC function in
altering the MIC for different antibiotics clinical isolates were
transformed with a plasmid expressing OmpC K12. These data
show a drastic reduction in the MIC (Table 1) for each strain when
OmpC K12 is expressed in the clinical isolates. We infer that
OmpC mediated transport of antibiotics into the cell is an
important component of clinical resistance. (As a control we tested
gentamicin resistance, which does not require transport through
the porin to the periplasm and the MIC was unchanged by the
presence OmpC.) Our purpose is not to compare OmpC K12
with OmpC20. OmpC K12 comes from a lab strain, as a result the
evolutionary processes lead to its current sequence are different.
The purpose of the experiment was to determine whether
transport of antibiotics into the clinical strains is a factor in the
observed resistance. The clinical isolates however exhibited
variations in porin (and other protein) expression that could
determine resistance. Thus, to deconvolute these confounding
factors (differential expression of OmpC and varying cellular
background) from any modification of transport properties that
accompany the change from OmpC20 to OmpC33, we undertook
a number of different biological assays of porin function under
conditions where expression levels and cellular background were
controlled. We chose three different isogenic strains that lack
functional porins (D9Omp and D8Omp) [20] and HN705 [21] to
isolate the effects of the three porin mutations from other factors.
D9Omp cells were transformed with low copy number plasmids
expressing either OmpC K12 (as a control) or one of the mutant
OmpC proteins derived from the clinical isolates. All of the porins
expressed to the same level within the limits of our detection (Fig.
S2). Porins are predicted to become rate limiting for growth when
the nutrient concentration is lowered [22]. No difference in growth
rates was observed between transformants, incubated in full
strength LB and thus, growth of the strains was assessed in diluted
LB media (diluted to 25% V/V with sterile H2O). A clear
differentiation between the parent strain transformed with the
empty plasmid (pHG575) and the strains expressing functional
porins was observed (Fig. 2a). The D9Omp strain failed to grow,
whereas all the strains expressing an OmpC protein grew
confirming all OmpC mutants were functional. The fastest growth
was observed with the OmpC K12 (similar rates observed for
OmpC20, OmpC26 and OmpC28) and the slowest with
OmpC33. The data clearly show that OmpC33 has different
transport properties from OmpC20 (OmpC26, OmpC28) which is
consistent with OmpC33 offering a diminished route of entry for
small organic molecules, such as the amino acids that are the
major nutrients for growth in broth [23,24] (Fig. 2a).
A similar differentiation between transport properties for the
porin variants was obtained from an analysis of antibiotic-
mediated cell killing. In the presence of cefotaxime (2 mgm l
21
in MHB medium) E. coli D8Omp cells transformed with OmpC
K12 were killed significantly faster than those expressing the
clinical mutants (Fig. 2b). In this assay, it is OmpC20 that is
significantly more sensitive to cefotaxime than the other clinical
OmpCs. However this pattern appears to be antibiotic-specific,
since cells expressing this OmpC33 actually exhibited increased
sensitivity to ceftazidime (relative to OmpC20, 26, 28 and even
K12); no change in imipenem sensitivity was observed (Fig. S3).
Cells with empty plasmid were the least sensitive, consistent with
OmpC being the route of antibiotic entry into these cells. As
expected gentamicin sensitivity was unaffected by the identity or
presence of OmpC, as this antibiotic has a different mode of action
and entry (Fig. S3d). Thus the changes in sequence between
OmpC20 and OmpC33 do differentially modify the sensitivity of
lab strain E. coli D8Omp to antibiotics. As an additional
experiment, sensitivity to cefotaxime was tested in HN705 cells
after complementation of the porin deficiency with either
OmpC20 or OmpC33 using the integrated cell metabolic activity
assay based on MTT (3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyl
tetrazolium bromide) reduction by viable cells [25]. Expression
levels of the porin were identical and thus did not affect the assay
outcome (Fig. S2). When metabolic activity is reduced by addition
of an antibiotic, less formazan is produced [25]. HN705 cells
expressing OmpC20 produced consistently less formazan in the
presence of cefotaxime than HN705 cells expressing OmpC33
(Fig. 2C). This indicates a reduction in the effect of cefotaxime
upon the metabolic activity of cells expressing OmpC33 consistent
with the decreased transport relative to cells expressing OmpC20.
Antibiotic penetration was also determined by the relative rate
of b-lactam (cephaloridine and cefazolin) hydrolysis using the
classical Zimmerman and Rosselet protocol [26]. The permeabil-
ity of the porin in whole cells is determined by dividing the rate of
hydrolysis of b-lactam in intact cells by the rate of hydrolysis of
lysed cells [5]. We conducted this assay with the original clinical
Table 1. Reduction of MIC by co-expression of OmpC K12 in
the clinical E. coli isolates.
Isolate 20 26 28 33
pOmpC K12 2 + 2 + 2 + 2 +
Cefotaxime 0.25 0.06 .32 4 .32 4 .32 32
Imipenem 0.25 0.12 1 0.5 1 1 8 0.5
Gentamicin 1 1 1 1 1 1 2 2
Antibiotic susceptibility testing was performed using M.I.C. Evaluator strips in
Mueller-Hinton broth. The following antibiotics were studied: cefotaxime,
imipenem and gentamicin. MIC values given are mgm l
21. Clinical isolates were
tested in parallel with these same isolates transformed with a plasmid a plasmid
carrying the ompC K12 gene.
doi:10.1371/journal.pone.0025825.t001
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PLoS ONE | www.plosone.org 3 October 2011 | Volume 6 | Issue 10 | e25825Figure 2. Evidence that mutation in OmpC affects cell viability. (a) LB growth curve: Domp9 cells transformed with the empty vector (navy
squares), OmpC20 (purple squares), OmpC26 (green triangles), OmpC28 (cyan diamonds) and OmpC33 (red circles) were grown in LB medium to mid-
exponential phase and then diluted 1 in 10 into 15% diluted LB medium to give a final 25% strength LB culture. The Domp9 cells transformed with
OmpCK12 are not shown as they followed the OmpC20 curve (see Fig. S3a). A representative example of three replicates is shown. (b) Antibiotic
inhibition of viability: Viability assays were performed with Domp8 cells transformed with the empty vector pHSG575, OmpCK12, OmpC20, OmpC26,
OmpC28 and OmpC33 (colours and symbols as (a) except OmpCK12 (magenta diamonds))) treated with 10 mgm l
21 cefotaxime at t=0. The mean 6
SD is shown (see also Fig. S3). (c) Metabolic inhibition by cefotaxime of HN705 cells expressing OmpC20 and OmpC33. A bar chart shows the extent
of metabolic inhibition in the presence of antibiotics. The precise values obtained in this experiment varied but the trend was consistent (OmpC33
more resistance than OmpC20). Figure S8 shows a divergent set of data. (d) Antibiotic penetration was also determined by the relative rate of b-
lactam (cephaloridine and cefazolin) hydrolysis in clinical isolate 1 which expresses OmpC20 (black) and clinical isolate 7 which expresses OmpC33
(white). (e) Liposome swelling assay. The rates of permeation of arabinose, glucose and N-acetylglucosamine into phosphatidylcholine liposomes
reconstituted with OmpCK12 (black), OmpC20 (white) and OmpC33 (red) were measured using the liposome swelling assay [4].
doi:10.1371/journal.pone.0025825.g002
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lactamase activity. By using this ratio, the process normalizes for
this variation in activity of the endogenous complement of b-
lactamase enzymes thus allowing comparison between strains
where the intrinsic b-lactamase activity may vary. The rate of
penetration of the cephaloridine decreased 20-fold for the clinical
isolates expressing OmpC33 relative to OmpC20 and cefazolin
uptake was undetectable in isolates expressing OmpC33 (Fig. 2d).
Finally, the permeability of the porins OmpC20 and OmpC33
to sugars was assessed using the purified proteins reconstituted into
phosphatidylcholine proteoliposomes, using OmpC K12 as a
reference [4]. Carbohydrate transport through the porin into the
liposomes causing them to swell due to water movement into the
liposome lumen. Thus over a fixed time period, the increase in size
is related to the rate of transport of sugar into the liposome.
Significantly slower entry of sugars (arabinose, glucose and N-
acetylglucosamine) was observed into liposomes containing
OmpC33 compared to those containing OmpC20 (the entry rate
for OmpC20 differs little from OmpC K12) (Fig. 2e).
Ion flow through different OmpC mutants
We performed a series of single molecule conductance
measurements on each OmpC mutant to determine whether the
changes observed above were replicated in the movement of small
ions, which would indicate a major change in pore diameter. We
observed a broad range of conductance values ranging from
,0.6 nS to ,3.0 nS for all the OmpC mutants (n$200), which
can be fitted to three Gaussian distributions. The peak
conductance values were in the ratio 1:2:3. Voltage-dependent
closure (vide infra) indicates the three peaks correspond to insertions
with one, two or three open channels. Thus the four mutants had a
mean trimer conductance between 2.460.4 nS and 2.660.4 nS
(Fig. 3a). The conductance is similar to the approximately 2.5 nS
reported for OmpC K12 in the same electrolyte [27,28].
Continuous channel insertions producing quantized jumps in
conductance measured at +50 mV (Fig. 3B) show that for
OmpC33 significantly more insertions fall into the lower two
(‘‘monomeric’’ and ‘‘dimeric’’) conductance steps than for any of
the other three mutants (Fig. 3C).
OmpC protein has previously been shown to undergo the
voltage-dependent gating [29]. At voltages above 6220 mV, all
mutants undergo a three-step closure reducing the conductance to
near zero, a process we conclude reflects sequential closure of each
monomer in the trimer (Fig. 3d). These data indicate that there are
no major changes in either ion conduction or general porin
properties and thus that the changes in antibiotic and sugar
transport are a consequence of more subtle alterations in structure.
Thus we determined the structures of the different mutant porins.
Structures of the OmpC mutants
Although the structure of OmpC K12 was known [12] the large
number of sequence changes (including insertions and deletions)
between it and the clinical mutants, made, in our judgment, in silico
modeling of OmpC20 unreliable and as a result any functional
inference drawn from such a model would lack robustness.
Therefore, we experimentally determined the crystal structures of
five OmpCs (OmpC20, OmpC26, OmpC28, and OmpCO6) at
resolutions ranging from 2.3–2.85 A ˚ but we were only able to
obtain a 3.55 A ˚ resolution data set for OmpC33 (Table 2). We
were unable to obtain higher quality data for OmpC33; this
variant seems more prone to aggregation and gave poor quality
crystals. All structures are trimeric and share the characteristic
porin 16-stranded antiparallel b-barrel [11,12]. The structures
superimpose with an average root mean square deviation (r.m.s.d.)
of 0.3 A ˚ for all Ca atoms (Fig. 1a). The b-strands are connected by
8 short turns (2–8 residues in length) on the periplasmic side and 8
long loops (L1 to L8 of 9–30 residues in length) on the extracellular
face. L3 folds back into the lumen of the barrel forming the
constriction zone and the trimer interface is formed by the packing
of hydrophobic residues on the outer edges of strands b1t ob5 and
further stabilized by L2 which reaches into the neighboring
monomer. In the trimer, the outside surface resembles a bowl with
the walls of the bowl formed by the loops 1, 4, 5, 6, 7 and 8 from
each monomer.
Figure 3. Single channel measurement on OmpC proteins. (a) Distribution of conductance values from individual insertions obtained from
current recordings, in 1 M KCl, 10 mM Tris, pH 8.0, at +50 mV. Three Gaussian peaks with freely varying centres and widths were fitted to each
conductance histogram. (b) Typical consecutive channel insertions of OmpC33 measured in 1 M KCl, 10 mM Tris, pH 8.0, +50 mV, 100 Hz low-pass
filter. Arrows indicate non-trimeric insertions in this segment. (c) Percentage of individual insertion steps that were not trimers for each OmpC mutant
studied. (d) Typical trace of voltage gating in a single OmpC20 trimer, and corresponding all-point conductance histogram recorded in 1 M KCl,
10 mM Tris, pH 8.0, +250 mV, 1 kHz low-pass filter.
doi:10.1371/journal.pone.0025825.g003
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OmpC K12 structure [12], with an alignment of 0.44 A ˚ r.m.s.d.
for 340 Ca atoms (Fig. S4). The majority of single residue
differences between the two homologs are located in the
extracellular loop regions: L2, L4 and L5. The sequence insertions
in L4 and L5 have resulted in modified structural arrangements of
these loops in OmpC K12 (Fig. S4a,b). There is a cluster of
substitutions in L2 (which forms the major trimer interface) but
these changes do not affect its overall conformation. The sequence
of the L3 constriction loop is highly conserved in all OmpC
homologs, with the only difference being G116 of OmpC K12
being substituted for an aspartic acid (D116) in OmpC20. The
conformation of L3 is virtually identical in both proteins.
Remaining substitutions are limited to several residues in beta-
sheets with membrane-exposed side-chains. The residues in
OmpC20 that this study highlights as being responsible for the
altered transport of antibiotics when mutated (D18, R124 and
D273) are all retained in OmpC K12. Examination of the
electrostatic surface calculated using CCP4MG shows that
OmpC20 has a more negatively charged entrance than either
OmpC K12 or the presumed parent OmpC O6 (Fig. S5).
Interestingly, the appearance of the electrostatic surface is closer to
OmpC K12 than the presumed parent OmpCO6, despite the
greater sequence differences. This is reflected in the slightly higher
r.m.s.d of 0.49 A ˚ for 343 atoms when superimposing OmpCO6
and OmpC20. In the clinical OmpC mutants, L4 is shorter
however interactions of L4 with L1 are conserved. In OmpC20 a
transverse electrostatic field is formed by K16, R37, R74, R124 on
one side with D18, D105, E109 on the opposite face, the identical
transverse field is seen in OmpC K12 [12] and a very similar one
in OmpF [11]. The narrowest point at the constriction zone, as
defined by HOLE [30], has a radius of 2.9 A ˚ in all structures (Fig.
S4c). Examining the pathway of the imaginary sphere used by
HOLE [30] to measure radius, reveals that the largest differences
between OmpC20 (and 26, 28, 33) and OmpC K12 (and
OmpCO6) occur in extracellular cavity above the constriction
zone where the channel radius is narrowed by over 1 A ˚ in
OmpC20 (and 26, 38, 33), due to changes in L3 and L4 (Fig. S4c).
The mutations observed in going from OmpC20 to OmpC33
cluster around the constriction zone. In OmpC26 (D18E), the
longer side chain of glutamic acid protrudes into the lumen
making a new salt bond to K16 (Fig. 4a). A water molecule bound
to the carboxyl group of 18E makes a new hydrogen bond network
with E109 and Y310. The presence of this mutation slightly
narrows the radius of the pore on the periplasmic side (below but
not at the constriction zone) (3.28 A ˚ to 2.95 A ˚). This creates in
OmpC26 an elongated constriction zone along the axis normal to
the membrane. In OmpC26 and OmpC20, a water molecule and
S271 are at the centre of a hydrogen bond network (Fig. 4B). In
OmpC28, the S217F mutation changes this network and moves
the tip of L3 (centred on E109) slightly further (,1A ˚) into the
pore (but not at the constriction zone). In OmpC33, R124 is
mutated to a histidine residue but due to the limited resolution of
this structure, we cannot experimentally assign the side chain
Table 2. X-ray data statistics of OmpC structures.
Data collection
Dataset OmpCO6 OmpC20 OmpC26 OmpC28 OmpC33
ESRF beamline ID14.1 ID14.3 BM14 ID14.1 ID14.3
Wavelength (A ˚) 0.934 0.931 0.976 0.934 0.931
Space group P6322 C2 P1 P63 P212121
Unit cell dimensions
a, b, c (A ˚) 120.4, 120.4, 158.1 128.0, 74.2, 133.5 74.2, 93.7, 115.9 103.5,103.5, 186.5 142.8,159.7, 164.6
a, b, c (u) 90, 90, 120 90, 124.75, 90 98.7, 108.8, 109.7 90, 90, 120 90, 90, 90
Resolution (A ˚)
Highest shell
47-2.5
(2.6-2.5)
110 - 2.5
(2.6-2.5)
29- 2.28
(2.34-2.28)
49–2.85
(2.9-2.85)
53 - 3.5
(3.7-3.5)
Rmerge (%) 10.5 (51.6) 11.7(63.2) 8.4(45.2) 11.8(74.2) 10.8(42.7)
Completeness (%) 99.5(99.5) 99.4(96.7) 97(96);
80(20)*
96(97) 85(73)
I/sI 14.3(3.4) 13.1(1.7) 9.9(1.8) 15.5(2.8) 7.1(1.8)
Redundancy 9.2(9.2) 3.6(3.0) 2.2(2.1) 8.1(8.1) 4.0(3.7)
Refinement
Resolution range (A ˚) 50-2.5 50-2.5 30-2.28 50-2.85 30-3.5
No. of unique reflections 24046 35609 118130;
95882*
25450 40939
Rwork/Rfree (%) 19.1/21.8 21.7/25.7 22.6/26.7 21.5/23.4 26.1/29.3
R.M.S deviations
Bond length (A ˚) 0.005 0.006 0.011 0.006 0.007
Bond angles (u) 0.88 0.99 1.36 0.96 0.95
Ramachandran outliers 0 0001 8 (0.9%)
Molprobity (score/centile) [61] 1.3/100 1.7/100 1.9 (94) 1.7 (100) 2.4 (99)
PDB code 2xe1 2xe2 2xe5 2xe3 2xg6
*These data are anisotropic, the completeness statistics relate to the data after manipulation to remove weak or absent measurements (see methods), the untruncated
data and truncated data have been deposited.
doi:10.1371/journal.pone.0025825.t002
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unaffected. In all the other OmpC proteins, R124 makes a salt
bridge with E66 (from the neighboring subunit L2) (Fig. 4C); the
shorter His residue must disturb the all three inter-subunit salt
bridges in the trimer. Thermal dissociation experiments shows that
the OmpC33 trimer decomposes into monomers at significantly
lower temperatures than the other isolates in two different
detergent systems (Fig. S6).
In the highest resolution structure (OmpC26) we can see
additional electron density in some of the six monomers, which we
modeled as SO4
22 bound by the basic residue cluster K16, R37,
R74 and R124 of the transverse electric field. Docking [15] and
molecular dynamics [31] have shown ampicillin bound to this
cluster in OmpF.
Molecular Dynamics
Molecular dynamics (MD) simulations were employed to
examine the effect of mutation on OmpC20 structure at ambient
temperature. The mutation D18E perturbs the hydrogen bonding
arrangement at the pore with its precise effect varying between
subunits. In two subunits the mutation slightly weakens the
hydrogen bond (salt contact) with K16 (60% vs 21% of simulation
time where contact is preserved) and creates a new contact with
R37 instead (Table 3). In the other subunit the D18E K16 contact
is stabilized (69% vs 41%), as seen in the OmpC26 and OmpC28
crystal structures. The S271F mutation does not appear to
influence hydrogen bonds. The R124H mutation disrupts the
critical hydrogen bond to the E66 from the loop 2 of the
neighboring subunit. Molecular dynamics shows this contact is
essentially abolished in two of the three monomers (Table 3). The
mutations R124H and D18E perturb the constriction zone, which
is manifested in the increased conformational variability of the
positive charges (R37, R74 and R124H) in OmpC33 when
compared to OmpC20.
Molecular dynamics suggests that the pore area of OmpC33
actually has very a small increase (within fluctuations) in the
constriction region compared to OmpC20 (Fig. S4d), consistent
with the crystal structures, which showed no difference in pore
radius (Fig. S4c). We analyzed the passage of cefotaxime through
OmpC20 and OmpC33 using metadynamics (Fig. 5a). The
calculations show a lower barrier for transit through OmpC20
than in OmpC33. During translocation through OmpC20,
cefotaxime penetrates with the aminothiazoly group down (the h
coordinate in Fig. 5a assumes values near 180u), interacting with
an arginine cluster at the constriction zone, (Fig. 5c). This type of
interaction with basic residues, has been seen in other porin-
mediated antibiotic transport pathways [31] as well in the
phosphate-specific transfer through the OprP channel [32]. While
on the extracellular side the reconstructed free energy surfaces
show the occurrence of all the allowed orientations for cefotaxime
in both channels, remarkably it penetrates through the OmpC33
constriction region in the opposite orientation (h near 0u, as shown
in Fig. 5a) and makes no specific interactions with the arginine
cluster (Fig. 5b). Instead it occupies the space between R37 and
R74, created by the disruptive substitutions R124H and D18E
(Fig. 5b). The calculation of the hydrogen bonds and hydrophobic
contacts between cefotaxime and the porin at the constriction
region shows a few persistent contacts in OmpC20 with contacts
tending to be more transient in OmpC33 (Fig. S7).
Discussion
Retention of porin function is required for virulence – it is
severely attenuated in a knockout mutant of the regulator ompR in
S. typhimurium (eliminating expression of both OmpC and OmpF)
[33], and the triple gene knockout ompC, ompF and aroC E. coli
strain is an avirulent candidate vaccine [34]. Thus, retention of
porin function was likely to be critical for the establishment of the
E. coli infection of the patient’s liver that resulted in the isolates
investigated in this study. Changes in outer membrane proteins are
recognized to be very important in the development of clinical
antibiotic resistance [3,8] but most reports from the clinic describe
diminished porin expression. Several in vitro studies have
constructed mutations in OmpF (and analogues) that partially
block the pore and so decrease antibiotic and small ion
Figure 4. Differences in OmpC structure caused by sequential mutation. (a) Close up of the first mutation site D18E in OmpC26. Residues
are colored as Fig. 1b, except for the mutated residue (18E), which is shown with dark grey carbon atoms. The mutation disrupts the hydrogen bond
network of D18 (which is shown with yellow carbons) and shifts one of the negative charges that forms the constriction zone at the active site. The
larger glutamic acid creates an unfavorable interaction (red dotted line) with E109. There are no other significant changes in structure. The orientation
is looking towards the periplasm from extracellular space, the positively charged cluster of residues on one side of the constriction zone are shown
and labeled. (b) Close up of the second mutation S271F, which along with D18E occurs in OmpC28. The larger hydrophobic phenyl group (labeled in
italic and shown with carbons colored grey) disrupts the hydrogen bonding network of S271 (shown for comparison) and causes a change in the
position of the constriction zone loop L3 (shown in salmon with E109 shown with carbons colored carbon and labeled) relative to OmpC26 (the loop
is colored purple with E109 in sticks and carbons colored salmon). Other atoms are coloured as Fig. 4a. The orientation is looking towards the
periplasm from extracellular space, the positively charged cluster of residues on one side of the constriction zone are shown and labeled. (c) Close up
of the site R124H, which occurs in OmpC33 along with D18E and S271F. The colour scheme is as Fig. 4a. The position of 124H (labeled in italic and
shown with grey carbons) is not accurate due to the low resolution of the OmpC33 structure but the salt contact of R124 (shown for comparison with
carbons colored yellow) with E66* (from the neighbouring subunit) which is important for trimer stability will be disrupted. The mutation will also
perturb the electrostatic field by removing a positive charge. The orientation is looking towards the periplasm from extracellular space, the other
positively charged cluster of residues on one side of the constriction zone are shown and labeled.
doi:10.1371/journal.pone.0025825.g004
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aspartate change on L3, has so far been observed in the clinic. It
reduces both ion flow and antibiotic permeation [9] consistent
with pore occlusion.
Point mutations of porins resulting in clinical resistance have
been only rarely characterized but are predicted to be important in
defending against carbapenem antibiotics [3]. The series of single
site OmpC mutations from E. coli that had co-evolved with drug
resistance presents a previously unstudied route to clinical
resistance [10]. The absence of OmpF in these isolates means
that OmpC is not only critical for nutrient acquisition but is also
the main pathway for antibiotic entry to the periplasm. The loss of
OmpF expression is common in many enterobacteria inhabiting a
human host and is presumed to occur because OmpC has a
smaller pore, is more suited to higher ionic strength and is in
general less permeable to b-lactam antibiotics [3]. Thus if OmpC
mutation can be demonstrated to contribute to clinical antibiotic
resistance it may represent a more widespread phenomenon,
fulfilling earlier predictions [3].
Relying solely on clinical data to evaluate the significance of the
OmpC mutants is hazardous since there are many simultaneous
and possibly confounding mechanisms [10]. The role of the three
porin mutations observed in the clinic in increasing resistance to
some antibiotics is supported by a range of analyses in well-defined
E. coli strains and with the purified proteins. The transformation of
the clinical isolates with plasmids expressing OmpC K12
dramatically lowered the MIC for cefotaxime (Table 1), consistent
with porin function having a significant role in the overall portfolio
of drug resistances. Transforming isogenic porin-deficient E. coli
with different ompc genes from the clinical isolates allowed us to
focus on the functional consequences of the OmpC mutations that
occur in the clinic. The mutated OmpC proteins are functional,
but there are detectable differences in growth rates amongst the
mutants under low nutrient conditions that are predicted to
increase the importance of porins for nutrient acquisition [22].
Direct measurement of cell survival shows that a porin-deficient
strain of E. coli transformed with OmpC26, OmpC28 or OmpC33
is, in each case, less sensitive to cefotaxime than the same strain
transformed with OmpC20. Measurement of cell metabolism by
MTT reduction also indicates that a porin deficient E. coli strain
transformed with OmpC33 is less permeable to cefotaxime than
one transformed with OmpC20. In a cell free (liposome) system,
OmpC33 has reduced transport properties compared to OmpC20
for sugars (uncharged polar molecules that are smaller than the
antibiotics) (Fig. 2f). Transit of imipenem was however insensitive
to the sequence of OmpC, confirming as we expected that in the
clinic there are other factors involved in resistance. Interestingly
the change in sensitivity to cefotaxime (OmpC20 to OmpC26)
correlates with the introduction of this antibiotic into the regime
prior to the isolation of strain 4 (the isolate in which OmpC26 was
first detected) [10]. The change in antibiotic sensitivity is not a
blanket reduction against all antibiotics, since ceftazidime is more
effective against cells transformed with OmpC33 than any other
OmpC variant (Fig. S3).
In summary, a divergent set of experiments paints a compelling
picture that the three mutations observed in changing from
OmpC20 to OmpC33 significantly alters the passage of molecules
through the porin. Further, these changes have measurable
outcomes on the resistance of isogenic clinical E. coli strains to
antibiotics. We do not address the differences between OmpC20
and OmpC K12. OmpC K12 was used only as a positive control
in our assays and was not found in the clinical study. Our focus
was to identify any correlation between antibiotic resistance and
the three sequence changes in OmpC that occurred in the clinic.
Interpreting the multiple changes in sequence and the different
evolutionary history of OmpC K12 and OmpC20 (26, 28 & 33),
which would be involved in such a comparison, are beyond the
scope of this present study.
The simplest method of engineering resistance is to disrupt the
pore size, seen in G112D mutation in Omp36, an OmpC
analogue in Enterobacter aerogenes [9,35] which shows a significantly
decreased ion conductance. By contrast, single channel measure-
ments do not show any significant change in the average
conductance of OmpC20, 26, 28 and 33 (Fig. 3). It is generally
accepted that small ion conductance is correlated with pore size.
Experimental structural data and molecular dynamics both suggest
that the constriction zone size has not altered significantly between
OmpC20 and OmpC33 (Fig. S4c, d). Thus our data show changes
in antibiotic sensitivity are not correlated with any change in small
ion conductance and appear to rule out reduction in pore size as
the mechanism of transport reduction.
In the absence of evidence for major changes in the pore size,
we examined the structures in more detail to identify a basis for the
change in transport. The conserved structure of the constriction
zone in porins is recognized as key to controlling molecular
Table 3. The time that a hydrogen bond is present in
molecular dynamics 45 ns simulation of OmpC20 and
OmpC33.
OmpC20 OmpC33
near S271F
N296(s) D312(s) 94% 98%
E109(m) D312(s) 60% 62%
N296(s)* D312(s)* 95% 99%
E109(m)* D312(s)* 48% 68%
N296(s)** D312(s)** 94% 97%
E109(m)** D312(s)** 57% 49%
near D18E
K16(s) D18(s) 65% -
K16(s)* D18(s)* 41% -
K16(s)** D18(s)** 55% -
K16(s) D18E(s) - 28%
K16(s)* D18E(s)* - 69%
K16(s)** D18E(s)** - 14%
R37(s)* D18(s)* 22% -
R37(s) D18E(s) - 81%
R37(s)* D18E(s)* - 0%
R37(s)** D18E(s)** - 84%
near R124H
R124(s) E66(s)** 111% -
R124(s)* E66 249% -
R124(s)** E66(s)* 91% -
R124H(s) E66(s)** - 0%
R124H(s)* E66 - 0%
R124H(s)** E66(s)* - 122%
100% indicates 1 hydrogen bond is present throughout the simulation, .100%
indicates more than one hydrogen bond.
(s) denotes a side chain interaction, (m) a main chain interaction,
*B subunit,
**C subunit.
doi:10.1371/journal.pone.0025825.t003
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to this region, all three residues are conserved in OmpC K12/
OmpCO6 and R124 and S271 are conserved in OmpF. The
D18E change (OmpC26, 28 and 33) results in an additional salt
bridge with K16 in the crystals and molecular dynamics shows the
mutation perturbs the hydrogen bonding at the constriction zone
(Fig. 4a, Table 2). The S271F mutation (OmpC28, 33) seems to
have only a marginal effect on the constriction zone (Fig. S4c). The
bulkier phenyl side chain packs against the L3 loop and the L3
loop is as a result slightly displaced (,1A ˚) into the channel. The
aromatic ring fills a previously open pocket adjacent to the central
pore and but has little other effect. Both in the OmpC33 crystal
structure and in silico, the R124H mutation disrupts the three salt
bridges with E66 of loop 2 found in the trimer. Protein thermal
stability tests confirm that the OmpC33 trimer does indeed
breakdown into monomers more easily than OmpC20 (Fig. S6).
This instability may also be reflected in the more frequent
simultaneous insertion of only one or two conducting monomers in
OmpC33 compared to OmpC20 (Fig. 3C). When the equivalent
arginine residue (R132) was mutated to an aspartic acid in OmpF,
trimer destabilization also occurred [38]. We do not believe that
trimer destabilization is the principal cause of altered permeation
for the following reasons; OmpC26 and OmpC28 are stable but
are, like OmpC33, less permeable to cefotaxime, OmpC33 is
functional (Fig. 2a) and conducts small ions as a fully open trimer
(Fig. 3), OmpC33 can be purified and crystallized as a trimer and
finally OmpC33 transformants are actually more sensitive to a
different antibiotic (Fig. 2B and S3).
Figure 5. Molecular dynamics analysis of cefotaxime penetration. (a) Free energy surface reconstructed from metadynamics simulations for
the translocation of cefotaxime in OmpC20 (left) and OmpC33 (right). Plotted are h (the orientation of the molecule) on X-axis against Z (distance
along the pore). A blue line indicates the lowest energy route from the extracellular space (+ve values of Z, top of the Figure) to the periplasm (2ve
values of Z, bottom of the figure). The circled region represents the most likely conformation at the constriction region (Z approximately -2). The color
scheme goes from black to white passing through red and yellow to indicate respectively regions with high probability of occupation (minima of the
free energy or affinity sites) and with low probability (maxima of the free energy or transition states). Each line represents a difference of 1 kcal/mol in
energy. (b) Snapshots extracted from the molecular dynamics trajectory showing cefotaxime at the constriction zone (the circle in Figure 5(a)) of
OmpC20 (left) and OmpC33 (right). There is a very prominent difference in the orientation and binding of the cefotaxime at the constriction zones of
the two proteins.
doi:10.1371/journal.pone.0025825.g005
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through OmpC20 and OmpC33 shows different barriers and
trajectories (Fig. 5) with a higher barrier to transit observed for
OmpC33 than OmpC20. Transit is governed by the interactions
with the residues that form the transverse electric field; K16, R37,
R74, R124 on one side D18, D105, E109 on the other [14,39,40].
Shape and charge of the transiting molecule play significant roles
and govern their interactions with the porin thus determining
transit efficiency [4,5]. The D18E mutation alters the position of
one of the negative charges on one side of the constriction zone
and the R124H mutation removes a positive charge on the other
side. This change in the spatial distribution of charges at the
constriction zone by definition alters the transverse electric field.
Interestingly molecular dynamics suggests that the side chains of
the charged residues are more flexible in OmpC33. A molecular
dynamics analysis shows that cefotaxime adopts a very different
orientation making very different interactions with the protein
inside the constriction zone of OmpC33 compared to OmpC20
(Fig. 5a). We suggest this underlies the difference in sensitivity to
cefotaxime that we observe. We note that cefotaxime has a
negative charge and thus may be the most sensitive to changes in
the transverse electric field. The large number of polar groups in
carbohydrates which require desolvation and stabilization during
transit may make these molecules particularly sensitive to these
changes, possibly explaining the decreased rate of entry into
liposomes containing OmpC33 (Fig. 2e).
The biochemical study of mutations found in clinical strains of
pathogens can help to elucidate mechanisms of resistance. We
present clear evidence that subtle changes in OmpC observed in
clinical isolates of E. coli [10] altered antibiotic permeability and
thus cell viability. Our analysis shows polypeptide sequence
changes perturb the transverse electric field at the constriction
zone, but do not, (in contrast to most engineered mutations)
reduce the size of the constriction zone or passage of small ions.
Simulations show that the changes in charge distribution in
OmpC, as a result of mutation, reduce the transit of cefotaxime
through the constriction zones. This type of mutation seems to
balance retention of porin function against reduction in drug
influx. A recent survey of clinically important mutations in a
Pseudomonas aeruginosa outer membrane protein OprD [41]
identifies many mutations of the full length protein. Many (but
not all) of these mutations cluster near the constriction zone of the
OprD structure [42]. Mutations at positions 120 and 121 in the
porin IB of penicillin and tetracycline-resistant N. gonorrhoeae strains
are located at the constriction zone and (as with the OmpC
mutants) do not seem to perturb small ion flow but rather disfavor
antibiotic transit [43]. Thus there is evidence from clinical studies
that changes around the constriction zone may leave the pore size
and ion flow unchanged, presumably preserving cell viability,
while selectively perturbing the transit of large polar molecules
such as antibiotics into the cell.
Methods
Strains
The original strains isolated from the patient were designated 1
to 7 [10]. The porins studied here were derived from the following
isolates: OmpC20 isolate 1; OmpC26 isolate 4; OmpC28 isolate 5;
OmpC33 isolate 6.
Cloning, expression, purification crystallization and
stability of OmpC
The genes encoding OmpC protein from clinical E. coli isolates
and E. coli O6 were amplified by PCR using the forward primer
ompC10F (59-GTT AGG TGT CGA CTT CGC CAT TCC GC-
39), and the reverse primer ompC11R (59-AGA ACC GGT AAC
TTC AGT AGC GTG GG-39) and ligated into the expression
vector pHSG575 [44]. The sequences of the clones were verified
by DNA sequencing. Plasmid pHSG575 containing the variant
ompC genes was transformed into mutant E. coli strains lacking
porins [21].
Transformed cultures were grown at 37uC for 18–24 hours in
LB media containing 25 mgm l
21 chloramphenicol and 0.5% (w/
v) glucose. The cells were then pelleted by centrifugation at
6,0006g( 4 uC) for 15 min, and then lysed by sonication in 50 mM
sodium phosphate, pH 7.5, and 50 mM NaCl. Membranes were
resuspended in 2% (w/v) sodium N-lauroyl sarcosine and
incubated at 20uC for 2 hours, the supernatant was centrifuged
at 100,0006g( 4 uC) for 1 h. OmpCs were solubilized in 0.5% (w/
v) 3-(N, N-Dimethylmyristyl-ammonio) propanesulfonate (SB
3.14, Sigma) overnight at 20uC with stirring.
Proteins were applied to a POROS-HQ anion exchange
column pre-equilibrated with 50 mM sodium phosphate,
pH 7.5, 50 mM NaCl and 0.025% (w/v) SB3.14 and eluted with
1 M NaCl. Fractions containing OmpC were diluted into low salt
concentration and applied to the same column again in order to
exchange the detergent solution to a mixture of 0.6% (w/v) 2-
hydroxyethyloctylsulfoxide (HESO) and 0.1% (w/v) n-octylpo-
lyoxyethylene (OPOE), or 1% (w/v) n-octyl-b-D-glucopyranoside
(bOG). OmpC proteins were further purified by gel filtration
(Superdex 200, Pharmacia). Protein purity and integrity was
checked by SDS-PAGE and by MALDI-TOF.
Protein purified in 1% (w/v) bOG was added to NuPAGE
buffer (Invitrogen), and incubated for 10 min at various temper-
atures (35uC–100uC) then transferred to ice before loading onto
NuPAGE 4–12% Bis-Tris gels (Invitrogen) which were run at
200 V for 35 min and stained by Coomassie. Whole cell samples
were harvested and resuspended in 20 ml SDS solubilisation buffer
(20% (v/v) glycerol 2% (w/v) SDS, 0.12 M Tris-HCl, pH 6.8,
0.5 g L
21 bromophenol blue, 20 ml L
21 b mercaptoethanol) and
heated at 100uC for 10 min then run described above.
Crystals of OmpCO6, OmpC20 and OmpC26 were grown
using the detergent mixture of 0.6% (w/v) HESO and 0.1% (w/v)
OPOE at 20uC. Both OmpCO6 and OmpC20 grew from the
solution of 1 M ammonium dihydrogen phosphate and 0.1 M n-
(2-acetamido) iminodiacetic acid, pH 6.5. The best crystal of
OmpC26 was grown from 0.1 M ammonium sulfate, 0.1 M 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)-sodium
pH 7.5, 0.5 M di-sodium hydrogen phosphate dihydrate, and
0.5 M di-potassium hydrogen phosphate plus 0.1 M carbenicillin
di-sodium. Crystals of OmpCO6 and OmpC20 were cryopro-
tected for data collection at 100 K by the addition of 20% glycerol
to the mother liquor, OmpC26 by addition of 15% (v/v) glycerol.
The best crystal of OmpC28 was grown from 0.1 M HEPES,
pH 7.5, 0.15 M MgCl2, 21% (v/v) PEG400 plus 50 mM
carbenicillin disodium at 20uC using 1% (w/v) bOG. The best
crystal of OmpC33 was grown from 0.1 M HEPES, pH 7.5,
0.075 M ammonium sulfate, 22.5% (v/v) PEG400 at room
temperature. Crystals were cryoprotected for data collection at
100 K by increasing the PEG400 concentration to 31% (v/v).
Antibiotic transit
Plasmids pHSG575 OmpCK12, pHSG575 OmpC20, pHSG575
OmpC26, pHSG575 OmpC208 and pHSG575 OmpC33 trans-
formed into E. coli Domp8 cells [20] and MIC values determined as
previously described [18]. Following a published protocol [18], cells
were grown in liquid culture and the survival curves measured in the
presence of antibiotics at various concentrations. The relative
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normalizing cell density and then measuring the density of the
OmpC band on SDS gels of the cell pellet and detergent extracted
material. We found no difference in the expression level between the
various OmpCs.
Growth Experiments
Overnight cultures were grown at 37uC, 200 rpm, in LB
medium supplemented with 12.5 mgm l
21 chloramphenicol as
needed and then diluted into 20 ml fresh pre-warmed LB medium
to an OD650 nm of ,0.05. Cells were grown to mid-exponential
phase (OD650 nm,0.4) and diluted 10-fold into 32.5 ml pre-
warmed 5% (v/v) or 15% (v/v) LB medium. The 10-fold dilution
of the LB pre-culture carries over 10% LB into the culture giving
final concentrations of 15% (v/v) and 25% (v/v) LB. The OD650
was measured every 30 min.
Cell viability assays
Overnight cultures were grown at 37uC, 200 rpm in Mueller
Hinton broth (MHB) supplemented with 12.5 mgm l
21 chloram-
phenicol as needed and diluted into 20 ml fresh, pre-warmed
MHB medium to an OD650 nm of ,0.05. Cells were grown to
mid-exponential phase (OD650 nm,0.4) and then diluted 10-fold
into pre-warmed MHB medium containing one of 8 mgm l
21
cefotaxime, 2 mgm l
21 imipenem, 2 mgm l
21 ceftazidime and
2 mgm l
21 gentamicin (t=0). Samples were taken at various time
points and cell viability was determined by serial dilution of the
samples to 10
25 in MHB medium and spotting 365 ml drops of
each dilution onto MHB agar plates. Viable colonies were counted
after 16 h incubation at 37uC and the number of cells ml
21
calculated. The results are expressed as % survival, where the cell
ml
21 value at t=0 is taken as 100%.
MTT and MIC assay
The use of MTT to measure bacterial cell viability has been
described previously [45–51]. NAD(P)H-dependent oxidoreduc-
tases and dehydrogenases of metabolically-active cells cleave the
tetrazolium ring, yielding intracellular insoluble blue-magenta
MTT formazan crystals. The amount of MTT formazan
produced in a fixed time is proportional to the number of
metabolically-active cells. Plasmids pHSG575 OmpC20 and
pHSG575 OmpC33 transformed into HN705 cells were grown
in 10 ml LB at 37uC to an OD600 of 1.0 before harvesting. As
with the E. coli D8Omp cells, E. coli HN705 cells gave identical
levels of expression of both OmpC proteins. The cell pellets were
resuspended in PBS to give an OD600 of 0.4. A series of 10 ml
antibiotic solutions in PBS or PBS alone were added to 90 mlo f
resuspended cells along with 10 ml of 5 mg ml
21 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT,
Sigma). After incubation for 4 h at 20uC the cells the formazan
was extracted by the addition of 890 ml of acidified isopropanol.
The absorbance of each assay was measured at wavelength of
570 nm with the background absorbance at 690 nm subtracted. A
broad range of antibiotic concentrations was tested to identify the
effective region, before detailed measurements in triplicate for
each data point. The incubation without antibiotic for each
OmpC was defined as 100% metabolic activity for that particular
OmpC and inhibition expressed relative to this value. This
normalization step controls for any variability in the uptake of
MTT by the different OmpCs. Antibiotic and MTT are added
simultaneously and the assay integrates over the whole population
of cells for a fixed time period. The concentrations of antibiotics
used in the assay are significantly above the MIC values, this is
because it takes time for the effect of an antibiotic to be visible in a
population of E. coli population. Since production of formazan is
irreversible, up to the point the population becomes metabolically-
inactive due to antibiotic pressure, formazan will accumulate. We
found the results of this assay to be variable but the overall trend
was consistent. The most divergent set of experiments are shown
in Fig. S8. The route of entry of MTT into bacterial cells is not
known but E. coli HN705 cells without the OmpC plasmid are able
to produce similar amounts of formazan. The metabolic inhibition
is expressed by: %inhibition=(A570c–A570s)/A570c *100; A570c
is absorbance at 570 nm measured from cells with no antibiotic,
A570s is absorbance at 570 nm measured from cells with added
antibiotic.
MIC assays were performed in Mueller-Hinton broth according
to the M.I.C.Evaluator strip guidelines (Oxoid). An overnight
culture was diluted to an OD600 0.15 (,equivalent to MacFarland
standard of 1) and 500 ml of this diluted culture was spread onto a
Mueller-Hinton agar plate. Once the liquid had been absorbed by
the agar plate, an M.I.C. Evaluator strip was placed flat onto the
surface of the agar plate. The agar plate was incubated for 18 h at
37uC. The MIC values were read off the strip according to the
manufacturer’s instructions. The antibiotics tested were cefotax-
ime (32-0.002 mgm l
21), imipenem (32-0.002 mgm l
21) and gen-
tamicin (256-0.016 mgm l
21).
Cephalosporin uptake experiments
Cephalosporin uptake experiments were carried out with
cefaloridine and cefazolin according to the published method
[5,26]. A single colony was used to inoculate 5 ml of LB, which
was incubated, in a shaking incubator, overnight at 37uC. The
overnight culture was diluted 1:50 into pre-warmed LB containing
5 mM MgSO4. The culture was grown to about 100 Klett
(,OD650=0.8) and harvested. Subsequent procedures were
conducted at 20uC, since incubation on ice can cause leakage of
periplasmic proteins. The cell pellet was washed with 10 mM
sodium phosphate buffer pH 6, containing 5 mM MgCl2 and
resuspended in 3 ml of the same buffer (to give a concentration of
5 mg dry weight ml
21; 100 Klett=0.3 mg dry weight ml
21).
0.5 ml was spun at 3,000 rpm for 10 min. The supernatant from
this sample was retained and b-lactamase activity assayed to
quantify any background activity due to cell disruption.
The assay mixture contained sodium phosphate buffer pH 6.0
containing 5 mM MgCl2 (420 ml), cell suspension (30 ml)
(,0.15 mg dry weight) and 10 mM cephalosporin (50 ml).
Reagents and cells were mixed in a test tube and transferred to
1 mm path length cuvettes to minimize light scattering. The
absorbance at 260 nm was measured and the assay repeated at
least three times for each sample. Assays were performed with
supernatant, with intact cells and sonicated cells. Sonicated cell
extracts were prepared from the cell suspensions on ice (Sonic
Dismembrator, Artek Systems Corp. Farmingdale, NY, USA,
50% power setting) by using four 30 s pulses separated by cooling
periods. The assay of the extracts was repeated with different
concentrations of cephalosporin to determine the concentration at
which the hydrolysis rate was the same as that measured for the
intact cells. The influx rate and permeability coefficient of the cells
could then be calculated using the following equations:
Influx Rate ~ Change in cephalosporin concentration s-1 mg-1
P~Influx rate=Asurface|(C0-C1)
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C1 ~ internal cephalosporin concentration and
surface area of a cell (Asurface) ~ 132mm2=mg dry weight
Liposome Swelling Assay
The assay followed a published method [52]. 10 mM
dicetylphosphate (20 ml) and 100 mM phosphatidylcholine
(24 ml) were added to a clean, dry test-tube and dried under N2.
Benzene (300 ml) was added to each tube then removed with N2
followed by anhydrous ether (500 ml), which was removed with N2.
The tubes were then placed in a dessicator and the lipids dried
under vacuum for at least an hour. The lipid film was resuspended
in water (200 ml) (control) or water (200 ml) including 1–2 mg
protein to be inserted into the liposome. The solution was vortexed
and a sonic waterbath used to resuspend the lipid. The lipid-
protein mixture was dried under vacuum. The dried protein/lipid
film was resuspended in 10 mM Tris-HCl pH 8.0 (300 ml)
containing 15% (w/v) dextran T-40 (Pharmacia) by slowly adding
the later to the side of the test-tube and gently rotating the tube to
wet the film. The tubes were left at room temperature for 30 min,
shaken by hand and left for another 30 min.
The assay was carried out in 3 ml cuvettes and the change in
absorbance at 400 nm measured. A 600 ml total volume
contained: 60 ml 0.1 M Tris-HCl pH 8.0, x ml 0.1 M test solute
(where x was varied to establish iso-osmolarity). The components
were mixed in the cuvette, proteoliposome (17 ml) was added and
readings were taken immediately. Control measurements to
establish isotonic conditions were carried out with liposomes
lacking the porin by incubation with different concentrations of
stachyose (a solute which is impermeant to E. coli porins) to find a
concentration that caused neither swelling nor shrinking. The
assay was repeated with the other test solutes to ensure they were
isotonic. Having established these core conditions, the porin-
containing liposomes were assayed in triplicate with iso-osmotic
concentrations of solute using a variety of test solutes with differing
molecular weights (arabinose, glucose, N-acetyl-glucosamine). The
permeation rate was then calculated as the change in absorbance
min
21 (mg
21 of protein) which reflects liposome swelling.
Single channel conductance experiments
Single-channel recordings were carried out in solvent-free
planar lipid membranes [53]. Briefly, a 25-mm-thick Teflon film
(Goodfellow) with a 100 mm diameter orifice partitioned two
1.5 ml chambers. The orifice was pretreated with ,1 ml 1% (v/v)
hexadecane dissolved in high-purity pentane. Each chamber was
filled with 1 ml of 10 mM Tris-HCl, pH 8.0, 1 M KCl. Lipid
solution in pentane (10 ml, 4 mg ml
21) was added to each
chamber and a monolayer formed after pentane evaporation. By
lowering and raising the solution, a lipid bilayer was formed at the
orifice, confirmed by its resistance and capacitance. For single
channel measurements, 1,2-diphytanoyl-sn-glycero-3-phospho-
choline (Avanti Polar Lipids) (DPhPC) was used. For sequential
multi-channel insertions, DPhPC with 10 mol% cholesterol and 2
mol% 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) (both
Avanti Polar Lipids) was substituted to facilitate channel
reconstitution at low voltages. Transmembrane potential was
applied with two Ag/AgCl electrodes. The cis chamber corre-
sponds both to electrical ground and the side of protein addition.
Experiments were conducted at room temperature.
Single-channel currents were amplified with an Axopatch 200B
patch-clamp amplifier (Axon Instruments), and filtered at 1 kHz
with a built-in low-pass 4-pole Bessel filter. Signals were digitized
with a Digidata 1440 A/D converter at a sampling rate of 10 kHz
and recorded by Clampex 10.2 software (Axon). The data were
analyzed with the software pClamp 10.2 (Axon) and Origin 7.0
(Microcal Software Inc.). The insertion of a single trimeric
channels into the bilayer was facilitated by applying electrical
potentials of +250 to +300 mV, after addition of purified OmpC
in 1% bOG to a final concentration of 10 ng ml
21. Channels were
stabilized for recording by lowering the voltage to below
+250 mV. For continuous multi-channel insertions, final concen-
trations up to 0.5 mgm l
21 were used.
Structural biology
Data were collected at the European Synchrotron Radiation
Facility (Table 2), indexed and integrated using MOSFLM [54].
For OmpC26 multiple lattices were evident and the strongest
lattice within the resolution range 3 A ˚ - 2.3 A ˚ was selected for
indexing. POINTLESS [55] XTRIAGE [56] were used to assess
quality and assign the correct space group; data were merged with
SCALA [57]. Ellipsoidal truncation was performed for data of
OmpC26 [58] and this reduced completeness by 20%.
All the structures were solved using molecular replacement with
PHASER [59,60] or MOLREP [61]. The structure of OmpCO6
used OmpK36 from Klebsiella pneumoniae (PDB: 1OSM) as a model.
Subsequently OmpCO6 was used as the search model for the
other structures. Refinement and model building were carried out
using REFMAC5 [62] and Coot [63]. NCS restraints and TLS
refinement were employed. The stereochemical quality was
analyzed using MolProbity [64] and figures produced using
PYMOL (www.pymol.org).
Molecular Dynamics
We prepared OmpC20 starting from its X-ray structure. We
inserted the porin in a previously relaxed POPC bilayer where
after removal of overlapping molecules, we arrived to a system
with 215 POPC and solvated with 18582 water molecules
(hexagonal cell 1076107696 A ˚). We relaxed the system slowly
to 300 K (1.5 ns) maintaining both the position of the protein
restrained to the X-ray structure and the position of the POPC
headgroup fixed along the axis Z, to avoid the opening of the
bilayer. After releasing the restraint on POPC we relaxed for 4 ns
before neutralizing the box with the addition of counter ions (Na
+).
An additional relaxation of 10 ns was followed by 45 ns
simulations that we used for structural analysis. We considered
this long enough to properly sample the protein-protein interac-
tions. Due to the lower quality of OmpC33 X-ray structure, we
decided to start with the OmpC28 X-ray coordinates performing
the substitution R124H. Then we followed the same protocol as
above. We used the Amber99SB force field as before [65]. These
simulations were performed with the software NAMD, version 2.7.
We performed metadynamics simulations to investigate the
translocation of the anionic cephalosporin cefotaxime using the
program ORAC [66]. We set-up the antibiotic force field as
described [65] and we placed it in the relaxed structure of
OmpC20 and OmpC33 at the extracellular mouth channel,
approximately 14 A ˚ from the constriction region. As before
[65,67,68] enhanced sampling is used to ensure the simulation
accesses all the relevant conformational states of the antibiotic
inside the channels. On the basis of earlier findings [65,67,68] we
chose two relevant collective variables to bias the translocation of
cefotaxime: (i) the variable Z, defined as the difference between the
center of mass of the antibiotic and the center of mass of monomer
Antibiotic Resistant OmpC
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defines the orientation of the long axis of the molecule with respect
to the z-axis. A Gaussian potential was added every 4 ps with a
height of 0.48 kcal mol
21 and width of 0.4 A ˚ and 5.0u,
respectively, for the coordinates Z and h. These parameters were
chosen to allow a better resolution in the sampling of the free
energy surface (FES) in a simulation time of 27 ns and 31 ns,
respectively for OmpC20 and OmpC33. We estimated the total
error of our simulation strategy to be around 2 kcal mol
21 [68].
When cefotaxime penetrates with the aminothiazoly group the
coordinate h has a value near 180u, correspondingly it is near 0u in
the opposite orientation.
Due to the complexity of the process studied, we reconstructed
the free energy surface from metadynamics simulations after
obtaining the first and only translocation path, as done elsewhere
[31,68,69]. This first crossing is considered to be the most
probable path because it passes through the lowest saddle point.
The barrier is calculated as the difference between the lowest
minimum in the extracellular side and the saddle point after
passing the constriction region. This barrier, being the highest,
controls the flux of molecules, lower the barrier higher the flux.
Supporting Information
Figure S1 Sequence alignment of OmpC from clinical isolates
1
and OmpCO6 from uropathogenic E. coli O6:H1 (accession
no. Q8CVW1). The alignment was carried out in Multalin. Above
the alignment, the b-strands forming the barrel and the
extracellular loops connecting the b-strands are numbered. The
b-strands are labelled b1–b16 and b19. Strand b1 is from the N-
terminal and strand b19 is from the C-terminal are two parts of the
same strand. The residue numbering is according to that of
OmpCO6. The mutation sites between the clinical OmpC
mutants are highlighted in red.
(TIFF)
Figure S2 Expression of the cloned OmpC mutants in D8omp
(a) and HN705 (b) cells. (a) From left to right, Lane 1 is SeeBlue
marker and lanes 2–7 are whole cell protein samples correspond-
ing to D8omp strain no plasmid, D8omp strain expressing OmpC
K12, OmpC20, OmpC26, OmpC28 and OmpC33 respectively.
(b) From left to right, Lane 1,2,3 are whole cell protein,
corresponding to HN705 knocked out strain, HN705 expressing
OmpC20, and HN705 expressing OmpC33, respectively; lane
4,5,6 are outer membrane extractions of HN705 no plasmid, cells
expressing OmpC20 and OmpC33 respectively. Mass-spec
analysis showed that the major band in Lane 4 is PhoE which
appears upregulated in the absence of OmpC. ImageGauge
showed that the intensity of gel bands 5 and 6 were the same,
indicating the same expression level of OmpC20 and OmpC33.
Experimental details: (a) Cells were grown to OD650 0.4,
harvested and resuspended in 20 ml SDS solubilisation buffer (20%
(v/v) glycerol, 2% (w/v) SDS, 0.12 M Tris-HCl, pH 6.8,
0.5 g L
21 bromophenol blue, 20 ml L
21 b-mercaptoethanol)
heated at 100uC for 10 min, centrifuged and the gel loaded with
the supernatant (15 ml). (b) Lanes1–3: Cells were grown to OD600
1.0 and washed cells (20 ml) (wash buffer PBS, pH 7.4) were
incubated with 10 ml NuPAGE loading buffer (Invitrogen) heated
at 100uC for 10 min, centrifuged and the gel loaded with the
supernatant (18 ml). Lanes 4–6: 0.5 L of cells grown to OD600 1.0
harvested, disrupted and membranes collected by centrifugation at
100,000 g. Protein extraction followed the same procedure as for
protein purification (see methods). After SB3.14 extraction, 20 ml
outer membrane protein crude solution was incubated with 10 ml
NuPAGE loading buffer (Invitrogen) heated at 100uC for 10 min,
centrifuged and the gel loaded with the supernatant (15 ml).
Camera and software: FUJIFILM ImageReader LAS-1000 Pro
V2.3. Software: FUJIFILM ScienceLab 2003, ImageGauge
V4.21.
(TIF)
Figure S3 Evidence that mutation in OmpC affects cell viability.
(a) LB growth curve: Domp9 cells transformed with the empty
vector (navy squares), OmpCK12 (magenta diamonds) OmpC20
(purple squares), OmpC26 (green triangles), OmpC28 (cyan
diamonds) and OmpC33 (red circles) were grown in LB medium
to mid-exponential phase and then diluted 1 in 10 into 15%
diluted LB medium to give a final 25% strength LB culture. A
representative example of three replicates is shown. (b–d) Viability
assays were performed with 2 mg.ml
21 imipenem (b) 4 mg.ml
21
ceftazidime (c) 2 mg.ml
21 gentamicin (d) of DOmp8 cells
transformed with the empty vector pHSG575, OmpC K12,
OmpC20, OmpC26, OmpC28 and OmpC33 (colours as (a)). The
mean 6 SD of a minimum of 3 replicates are shown. (e)
Gentamicin susceptibility testing of each of the four clinical isolates
(open bars) in parallel with these same isolates transformed with a
plasmid carrying the ompC K12 gene (grey bars) was performed
using M.I.C.Evaluator strips in Mueller-Hinton broth.
(TIF)
Figure S4 (a) Superposition of OmpC20 (cyan), E. coli OmpC
K12 (ochre)and OmpCO6 (pink) In (a) Trimer shown looking into
the constriction zone towards the periplasm and (b) monomer
shown with periplasm at bottom and extracellular region at top
(almost 90u rotation from (a)). The loops L2, L3 and L4 are labeled
in the one monomer. The main differences in the structures occur
in L4 which folds across the timer interface and forms the entrance
to the constriction zone. OmpC20 has a shorter loop. L2 which
folds across the trimer interface in the neighboring monomer and
L3 which forms the constriction zone are essentially identical.
There are smaller differences in the other extracellular loops. (c)
Radius of central channel through the different OmpC’s crystal
structures, calculated by program HOLE [30]. The left hand side
of the graph corresponds to the periplasmic face (bottom of S4b)
and the right hand side to the extracellular space (top of S4b). The
constriction zone is about half down the 28 A ˚ long central
channel. (d) Area available to a probe of radius 1.4 A: averaged
over 20 ns MD simulation trajectories at T=300 K and P=1
Atm.
(TIF)
Figure S5 Electrostatic surface of OmpC. (a) OmpC K12 (b)
OmpCO6, (c) OmpC20 (d) OmpC26 (e) OmpC28 (f) OmpC33.
Pictures were generated in CCp4MG with the same parameters.
Blue is positive charge and red is negative charge. The view is
looking down into the constriction zone (from outside the cell into
the cell). The entrance to the pore is less occluded (shorter L4) and
more negatively charged in OmpC20 (26, 28 and 33) than in
either OmpC K12 or OmpCO6.
(TIF)
Figure S6 Comparison of thermal stability between OmpC’s. In
common with other trimeric porins, the folded OmpC trimer
although runs at a higher weight its runs close to the weight of the
monomer. (a) OmpC20 and OmpC33 were purified in 1% BOG
detergent and heated at a range of temperatures marked in uC. (b)
All clinically derived strains proteins were purified in the detergent
SB 3.14 detergent and heated to various temperatures. OmpC33 is
notably more prone to dissociation into monomers than the other
proteins.
(TIF)
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lifetime of hydrogen bond interactions between cefotaxime atoms
and OmpC20 residue atoms. (b) The lifetime of hydrogen bond
interactions between cefotaxime atoms and OmpC33 residue
atoms. The simulations were performed as described in the paper.
(TIF)
Figure S8 The most divergent repeat of the antibiotic inhibition
experiment. A different batch of cells and reagents were used.
Although the details of the results vary from Figure 2c, the trend
(OmpC33 more resistant) is consistent.
(TIF)
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